Elsevier

Progress in Retinal and Eye Research

Volume 55, November 2016, Pages 182-205
Progress in Retinal and Eye Research

The role of dinucleoside polyphosphates on the ocular surface and other eye structures

https://doi.org/10.1016/j.preteyeres.2016.07.001Get rights and content

Highlights

  • Dinucleoside polyphosphates are natural substances present in the eye.

  • These dinucleotides regulate tear secretion, wound healing and corneal permeability.

  • The dinucleotide Ap4A is a marker of dry eye in many pathological conditions.

  • Dinucleoside polyphosphates modulate intraocular pressure by acting on P2 receptors.

  • Dinucleotides can be used as therapeutic agents to treat several ocular pathologies.

Abstract

Dinucleoside polyphosphates comprises a group of dinucleotides formed by two nucleosides linked by a variable number of phosphates, abbreviated NpnN (where n represents the number of phosphates). These compounds are naturally occurring substances present in tears, aqueous humour and in the retina. As the consequence of their presence, these dinucleotides contribute to many ocular physiological processes. On the ocular surface, dinucleoside polyphosphates can stimulate tear secretion, mucin release from goblet cells and they help epithelial wound healing by accelerating cell migration rate. These dinucleotides can also stimulate the presence of proteins known to protect the ocular surface against microorganisms, such as lysozyme and lactoferrin. One of the latest discoveries is the ability of some dinucleotides to facilitate the paracellular way on the cornea, therefore allowing the delivery of compounds, such as antiglaucomatous ones, more easily within the eye. The compound Ap4A has been described being abnormally elevated in patient's tears suffering of dry eye, Sjogren syndrome, congenital aniridia, or after refractive surgery, suggesting this molecule as biomarker for dry eye condition. At the intraocular level, some diadenosine polyphosphates are abnormally elevated in glaucoma patients, and this can be related to the stimulation of a P2Y2 receptor that increases the chloride efflux and water movement in the ciliary epithelium. In the retina, the dinucleotide dCp4U, has been proven to be useful to help in the recovery of retinal detachments. Altogether, dinucleoside polyphosphates are a group of compounds which present relevant physiological actions but which also can perform promising therapeutic benefits.

Introduction

Dinucleoside polyphosphates are a family of dinucleotides related to others such as nicotinamide adenine dinucleotides (NAD and NADP), but slightly different in their structure. Dinucleoside polyphosphates comprise all those dinucleotides formed by two nucleosides bridged by a variable number of phosphates. The two nucleosides moiety can be formed by ribose which may present the same or different bases, either purines or pyrimidines (Fig. 1). Although in theory the possibilities of dinucleotides are enormous, simply by combining the nitrogenised bases and the phosphate length, there are only a few which have been recognised as naturally occurring dinucleoside polyphosphates, nonetheless, other dinucleoside polyphosphates have been synthesised either enzymatically or chemically (Guranowski et al., 1995, Mizuno and Sasaki, 1965, Ortiz et al., 1993). Dinucleoside polyphosphates can be named in different ways, for instance, α, ω dinucleoside polyphosphates, dinucleoside 5′, 5‴-P1, Pn polyphosphates or NpnN. The latter is the most common one in which “N” is substituted by the bases (A, G, U, for example) and “n” by the number of phosphates.

Dinucleoside polyphosphates found in biological systems are those formed by two adenosines, which are termed diadenosine polyphosphates, ApnA, the ones formed by guanosines, diguanosine polyphosphates, GpnG, or a combination of both, one moiety with adenosine and the other with guanosine (GpnA). Concerning the phosphate length linking both nucleosides, this can vary from two to seven, although the most common are those dinucleotides with 3–5 phosphates. Common, naturally occurring dinucleoside polyphosphates, according to the number of phosphates, are Ap5A or Gp4G.

Synthetic dinucleoside polyphosphates are relevant since they depict remarkable actions on ocular physiology (Guzman-Aranguez et al., 2007, Guzman-Aranguez et al., 2011). Among these the ones with uridine, diuridine polyphosphates (like Up4U AKA diquafosol), with deoxycytidine and uridine (dCp4U, also termed denufosol), or those with hypoxanthine, diinosine polyphosphates (IpnI), have demonstrated interesting therapeutic properties in the eye as it will later be described (Fujihara et al., 2001, Guzman-Aranguez et al., 2012).

The history of dinucleoside polyphosphates started far away from the future physiological and pharmacological applications found in the eye. Indeed, the first news on these molecules occurred in the 1960's. Dinucleoside polyphosphates were discovered in the eggs of brine shrimps, mostly diguanosine polyphosphates (Finamore and Warner, 1963, Warner, 1964). These dinucleotides are the basis for the development of the eggs into proper shrimps since they will be used for DNA synthesis.

It was not until a few years later when it was possible to identify a biochemical reaction showing the synthesis of a dinucleoside polyphosphate. Scientists, when investigating the reaction between aminoacids and their corresponding tRNAs during the protein synthesis process discovered the presence of some diadenosine polyphosphates (Randerath et al., 1966, Zamecnik et al., 1966). Over the following years, most of the efforts were dedicated to describing their structural and chemical properties, mainly by spectrometric methods (Bush and Tinoco, 1967, Cheng, 1968, Warshaw and Tinoco, 1965). Changes in the molecules present were also studied when environmental properties (Lee et al., 1979) such as temperature or pH was modified (Chan and Nelson, 1969, Davis and Tinoco, 1968, Glaubiger et al., 1968, Hruska and Danyluk, 1968, Ikehara et al., 1970, Rabczenko and Shugar, 1971, Ts'o et al., 1969). The structural changes are especially relevant when the pH medium is altered. The structure of a NpnN, for example, Ap4A, under physiological pH condition (pH ≈ 7), depicts a stacked conformation in which the adenine rings are piled up, this being possible due to the phosphate chain folding. This is caused by the negatively charged phosphate groups and the partially positively charged adenine rings and the consequent electrostatic interactions. A different panorama is observed when the pH lowers (pH ≈ 4). Under this condition the phosphates are folded but the adenine rings are pointing to opposite directions. The maximal open possible conformation is reached at a pH below 3. Under this condition the protonation of the phosphates occurs and the interactions among the adenines and phosphates do not exist (Guzman-Aranguez et al., 2011).

The conformational changes observed at different pH, may explain why these dinucleotides can interact with different purinergic receptors, mainly when in some environmental conditions, such as acidic synapses (glutamatergic) the conditions can be far from neutral conditions (Gualix et al., 2003).

Concerning temperature, it seems that dinucleoside polyphosphates at low temperatures present their bases in a stacking conformation being so close to each other that there is no room for water between them. On the contrary, when temperature is high, even at denaturing conditions (above 40 °C), the bases are not stacked and they do not interact with each other and therefore can interact with the solvent and other molecules. In this case, the only limitation of the aromatic bases would be their covalent bonds to the respective riboses (Davis and Tinoco, 1968, Glaubiger et al., 1968).

It took quite a long time from the moment these dinucleotides were identified until some biochemical and physiological actions for these compounds were detected. One of the first actions was the effect of diadenosine tetraphosphate, Ap4A, on DNA polymerase triggering DNA replication (Grummt, 1978, Grummt, 1979, Grummt et al., 1979). Indeed, it has been possible to correlate changes (increases) in Ap4A concentrations during the cell cycle and specially during cell proliferation and DNA synthesis (Bambara et al., 1985). These experiments were quite controversial, although other authors could, in part, confirm the relationship between Ap4A and DNA synthesis, it seemed that apparently the dinucleotide would prime DNA synthesis rather than activating the polymerase (Zamecnik et al., 1982). Also, some other studies suggested a close relation between the amino acid activation process and DNA replication in mammalian cells (Grummt, 1983, Rapaport et al., 1981).

Another intracellular action suggested for dinucleoside polyphosphates has been its possible role of “alarmone” (Lee et al., 1983, Varshavsky, 1983). An alarmone is a molecule that reflects and indicates a stress situation within a cell. A classical situation is that in which an elevation of temperature, apart from increasing the levels of heat shock proteins (HSPs), also produces a rise in dinucleoside polyphosphates such as Ap3A, Ap4A, Gp4A and Gp3A (Lee et al., 1983). The same dinucleotides are increased when cells are submitted to oxidative stress in a process independent from the dinucleotide synthesis by aminoacyl-tRNA synthetases.

Although the presence and actions of dinucleoside polyphosphates have been reported in several tissues as indicated (Andersson, 1989, Rapaport and Zamecnik, 1976, Ripoll et al., 1996), two sources are relevant concerning the eye physiology: the blood vessels and the nervous system.

Apart from the presence of dinucleoside polyphosphates in crustaceans as previously indicated, these molecules were found as putative active vasoactive compounds when they were discovered in platelet secretory granules (Flodgaard and Klenow, 1982, Luthje and Ogilvie, 1983). From the moment they were discovered the main interest of the scientific community was to identify those actions triggered by the dinucleotides in the blood stream. In this sense, one of the first roles was their involvement in platelet aggregation. Interestingly, the two dinucleotides contained in the platelets (in their dense granules), Ap3A and Ap4A, depicted opposite actions; while the first was inducing platelet aggregation, the second, showed disaggregating properties (Luthje et al., 1985). Nonetheless, the existence of dinucleoside polyphosphates in the plasma and blood (Luthje and Ogilvie, 1988), also suggested an effect on vasoconstriction or/and vasodilation. When analysing the effect of the vascular tone, dinucleoside polyphosphates such as Ap4U produces a biphasic effect although the predominant one at low concentrations is vasoconstriction, infusions of this dinucleotide elicit hypotension and electrolyte retention (Flores et al., 1999, Hansen et al., 2010).

The identification of dinucleoside polyphosphates and mainly diadenosine polyphosphates in neural secretory vesicles showed the storage of these dinucleotides with classical transmitters such as noradrenalin (Rodriguez del Castillo et al., 1988). This co-localization was further extended to cholinergic and monoaminergic synaptic vesicles (Miras-Portugal et al., 1998, Miras-Portugal et al., 1999, Pintor et al., 1992). Moreover, it was possible to demonstrate that these dinucleotides were releasable in a Ca2+ dependent manner from brain synaptic terminals (Pintor et al., 1991, Pintor et al., 1992) and also by the effect of drugs such as amphetamines (Pintor et al., 1993). The role of diadenosine polyphosphates, mainly Ap4A and Ap5A in the nervous system has been the modulation of the release of monoamines (Giraldez et al., 2001), glutamate (Gualix et al., 2003), or the inhibition of synaptic transmission in the hippocampus (Klishin et al., 1994).

Extracellular actions of dinucleoside polyphosphates occurred by means of receptors on the cell surface termed P2 purinergic receptors. These types of receptors are divided into two families, the P2X ionotropic (Habermacher et al., 2015) and the P2Y metabotropic receptors (von Kugelgen and Harden, 2011).

P2X receptors are activated by nucleotides and dinucleotides which mediate the rapid and non-selective cation transients (mainly Na+ and Ca2+) from the extracellular space (Samways et al., 2014), causing depolarization of the membrane ion channels and subsequent activation of voltage dependent calcium channels. Seven members of P2X receptors in mammalians have been cloned (P2X1-P2X7) and they combined various forms of these subunits (Saul et al., 2013). Cloning of P2X receptors has revealed that all the subunits have large extracellular loop with ten cysteine residues, two transmembrane domains and short intracellular C and N terminals (Roberts et al., 2006). Three subunits are necessary to form a functional native channel, and these channels are organized as homotrimers or heterotrimers (Coddou et al., 2011).

P2Y receptors are metabotropic receptors, members of the family of G protein-coupled receptors containing seven hydrophobic transmembrane domains connected by three extracellular loops and three intracellular loops, with an extracellular N-terminal end and another C-terminal oriented intracellularly (Jacobson and Boeynaems, 2010). These receptors are coupled, via G proteins to others, such as phospholipase C (PLC), adenylate cyclase or to ion channels (von Kugelgen and Hoffmann, 2015). To date, the P2Y family comprises eight members (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13 and P2Y14) encoded by different genes. They can be organized into two groups based on their specific G protein coupling. In one group, that includes the P2Y1, P2Y2, P2Y4, P2Y6 and P2Y11 receptors, are all coupled to Gq and the further activation of phospholipase C β, with the consequent formation of inositol triphosphate (IP3) and the mobilization of intracellular Ca2+. The other group includes the P2Y12, P2Y13 and P2Y14 receptors, associated with Gi proteins and inhibiting adenylate cyclase. The P2Y11 is the only thing that can be coupled to both Gs and Gq proteins (Jacobson et al., 2015).

Concerning the action of dinucleoside polyphosphates and the activation of P2 receptors, most of the research has been carried out for ApnA compounds (Hoyle et al., 2001). In this sense, diadenosine polyphosphates can activate all the P2X receptors (Wildman et al., 1999), including the heteromeric P2X2/3. It is noteworthy to indicate that the most active dinucleotide has been Ap4A in most cases. (Pintor and Miras-Portugal, 1995b). Also, the P2X7 was only sensitive to these dinucleotides at concentrations above 1 mM, this effect being far from the physiological concentrations of these compounds.

Regarding the P2Y receptors, P2Y1 and P2Y2 are the ones that are stimulated by diadenosine polyphosphates (Patel et al., 2001). The tandem Ap4A-P2Y2 is of special interest since it participates in many physiological processes in many ocular structures (Fig. 2 see below).

The concentration of dinucleoside polyphosphates is tightly regulated by a variety of enzymes, mainly hydrolases that are present in all organisms and generally act on the polyphosphates chain of these molecules. The enzymes involved in the catabolism of dinucleoside polyphosphates have been reviewed by Guranowski (Guranowski, 2000).

Extracellular dinucleotides, which regulate physiological processes via P2 receptors activation, are degraded principally by ecto-nucleotide pyrophosphatase/phosphodiesterases (NPPs) (Asensio et al., 2007, Vollmayer et al., 2003). This family of enzymes are hydrolases located on cell surface and are a type of the so called ecto-nucleotidases (Zimmermann et al., 2012). In vertebrates, NPPs have seven members (NPP1–NPP7) but only three (NPP1–NPP3) can degrade nucleotides (dinucleotides but also nucleoside triphosphates and diphosphates) (Goding et al., 1998, Jin-Hua et al., 1997, Stefan et al., 1999). Dinucleotides degradation by NPPs produce nucleoside monophosphates (NMP) plus nucleoside polyphosphates (NPn−1). Therefore, NPPs can generate metabolites biologically active such as ADP and ATP that are obtained from the naturally occurring diadenosine polyphosphates (Vollmayer et al., 2003, Zimmermann, 2000). These nucleotides can also be degraded by NPPs and essentially through ecto-nucleoside triphosphate diphosphohydrolases (NTPDases), other family of ecto-enzymes that can degrade nucleoside triphosphates and diphosphates (Zimmermann, 1999).

On the other hand, the degradation of diadenosine polyphosphates and their metabolites ATP as well as ADP produce AMP. This nucleoside monophosphate can also be catabolized through ecto-5′-nucleotidase (eN) as well as alkaline phosphatase enzymes (this last ecto-nucleotidase may also act on ATP and ADP molecules) (Zimmermann et al., 2012). Consequently, AMP is converted into the nucleoside adenosine, which mediates purinergic effects via P1 receptors interaction (Jacobson and Gao, 2006).

Finally, extracellular adenosine can be eliminated from the synaptic cleft through cell surface adenosine deaminases that convert adenosine to inosine and/or nucleoside transporters (Bonan, 2012, Franco et al., 1997, Pastor-Anglada and Perez-Torras, 2015). These transporters, equilibrative and concentrative nucleoside transporters, are integral membrane proteins implicated in the cellular uptake of adenosine (Bonan, 2012, Pastor-Anglada and Perez-Torras, 2015).

Section snippets

Ocular surface

The ocular surface is the outer zone of the eye. It is a functional unit composed of different structures such as corneal and conjunctival epithelium, lacrymal glands, eyelids and tear film. All components of this functional unit are linked through the innervation and vascular immunologic and endocrine systems. The main functions of the ocular surface are to maintain the transparency of the cornea (optic quality issues) and to hydrate and protect the corneal and conjunctival epithelium to the

Conclusions and future directions

The participation of dinucleoside polyphosphates in ocular physiology opens the possibility of using these compounds for the treatment of relevant eye pathologies. Beginning with the ocular surface to the retina, the application of these dinucleotides may help to improve several processes, which may be altered in the pathology.

Dry eye is treated in some countries such as Japan and South Korea by means of the dinucleotides Up4U. This nucleotide can clearly increase tear secretion, both the

Disclosure

All authors have no financial interest in the subject matter or materials discussed in this manuscript. The authors alone are responsible for the content and writing of the paper.

Acknowledgments

This work was supported by grants from Ministerio de Ciencia e Innovación (SAF2010-16024 and SAF2013-44416-R) and RETICS (RD12/0034/0003).

References (326)

  • P.Y. Cheng

    Characteristic optical rotatory dispersion spectra of thirteen dinucleoside phosphates with mercurials

    Biochem. Biophys. Res. Commun.

    (1968)
  • M.S. Cowlen et al.

    Localization of ocular P2Y2 receptor gene expression by in situ hybridization

    Exp. Eye Res.

    (2003)
  • A. Crooke et al.

    Nucleotides in ocular secretions: their role in ocular physiology

    Pharmacol. Ther.

    (2008)
  • C.O. Dominguez-Godinez et al.

    In Vitro and in Vivo delivery of the secretagogue diadenosine tetraphosphate from conventional and silicone hydrogel soft contact lenses

    J Optom.

    (2013)
  • A. dos Santos-Rodrigues et al.

    Differential adenosine uptake in mixed neuronal/glial or purified glial cultures of avian retinal cells: modulation by adenosine metabolism and the ERK cascade

    Biochem. Biophys. Res. Commun.

    (2011)
  • N.M. Elsherbiny et al.

    Potential roles of adenosine deaminase-2 in diabetic retinopathy

    Biochem. Biophys. Res. Commun.

    (2013)
  • F.J. Finamore et al.

    The occurrence of P1, P4-diguanosine 5′-tetraphosphate in brine shrimp eggs

    J. Biol. Chem.

    (1963)
  • J.L. Flanagan et al.

    Role of lactoferrin in the tear film

    Biochimie

    (2009)
  • R. Franco et al.

    Cell surface adenosine deaminase: much more than an ectoenzyme

    Prog. Neurobiol.

    (1997)
  • H. Franke et al.

    P2X(7) receptor-mRNA and -protein in the mouse retina; changes during retinal degeneration in BALBCrds mice

    Neurochem. Int.

    (2005)
  • R. Frohlich et al.

    Pharmacological characterization of P2 purinoceptor types in rat locus coeruleus neurons

    Eur. J. Pharmacol.

    (1996)
  • T. Glaser et al.

    Absence of PAX6 gene mutations in Gillespie syndrome (partial aniridia, cerebellar ataxia, and mental retardation)

    Genomics

    (1994)
  • M. Guillon et al.

    Tear film evaporation–effect of age and gender

    Cont. Lens Anterior Eye

    (2010)
  • A. Guranowski

    Specific and nonspecific enzymes involved in the catabolism of mononucleoside and dinucleoside polyphosphates

    Pharmacol. Ther.

    (2000)
  • A. Guranowski et al.

    Conversion of adenosine(5′) oligophospho(5′) adenosines into inosine(5′) oligophospho(5′) inosines by non-specific adenylate deaminase from the snail Helix pomatia

    Biochim. Biophys. Acta

    (1995)
  • A. Guzman-Aranguez et al.

    Focus on molecules: purinergic P2Y(2) receptor

    Exp. Eye Res.

    (2012)
  • A. Guzman-Aranguez et al.

    Dinucleoside polyphosphates in the eye: from physiology to therapeutics

    Prog. Retin Eye Res.

    (2007)
  • A. Guzman-Aranguez et al.

    Focus on molecules: diadenosine tetraphosphate

    Exp. Eye Res.

    (2011)
  • A. Guzman-Aranguez et al.

    Effect of diinosine polyphosphates on intraocular pressure in normotensive rabbits

    Exp. Eye Res.

    (2012)
  • B.K. Harvey et al.

    Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration

    Neurotoxicology

    (2009)
  • M.P. Abbracchio et al.

    Roles of P2 receptors in glial cells: focus on astrocytes

    Purinergic Signal

    (2006)
  • S. Akanuma et al.

    Na+-independent nucleoside transporters regulate adenosine and hypoxanthine levels in Muller cells and the inner blood-retinal barrier

    Invest.Investig. Ophthalmol. Vis. Sci.

    (2013)
  • M. Ali et al.

    Clinical evaluation of corneal biomechanical parameters after posterior chamber phakic intraocular lens implantation

    Cornea

    (2014)
  • R. Arita et al.

    Topical diquafosol for patients with obstructive meibomian gland dysfunction

    Br. J. Ophthalmol.

    (2013)
  • R.R. Arnold et al.

    A bactericidal effect for human lactoferrin

    Science

    (1977)
  • R.A. Bambara et al.

    Is Ap4A an activator of eukaryotic DNA replication?

    Cancer Invest.Investig.

    (1985)
  • A.P. Biriukov et al.

    [Effect of diadenosine oligophosphates (Ap4A and Ap3A) and their phosphonate analogs on catalytic properties of phenylalanyl-tRNA synthetase from E. coli]

    Bioorg Khim

    (1987)
  • C.D. Bonan

    Ectonucleotidases and nucleotide/nucleoside transporters as pharmacological targets for neurological disorders

    CNS Neurol. Disord. Drug Targets

    (2012)
  • I. Boucher et al.

    The P2Y2 receptor mediates the epithelial injury response and cell migration

    Am. J. Physiol. Cell Physiol.

    (2010)
  • K.A. Bowman et al.

    Corneal epithelial healing rates after topical nucleotides

    Curr. Eye Res.

    (1981)
  • J.S. Braun

    Ecto-5′-nucleotidase-positive cells in the choroid and ciliary body of the rat eye

    Anat. Rec. Hob.

    (2010)
  • D. Bremond-Gignac et al.

    Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjogren's syndrome

    Expert Opin. Drug Metab. Toxicol.

    (2014)
  • N.A. Brennan et al.

    A review of the theoretical concepts, measurement systems and application of contact lens oxygen permeability

    Ophthalmic & Physiol. Opt. J. Br. Coll. Ophthalmic Opt.

    (1987)
  • L.G. Burman et al.

    Lysozyme–an enzyme of both historical and current interest as a therapeutical agent

    Lakartidningen

    (1991)
  • C.A. Bush et al.

    Calculation of the optical rotatory dispersion of dinucleoside phosphates

    J. Mol. Biol.

    (1967)
  • M.J. Velasco Cabrera et al.

    Lactoferrin in tears in contact lens wearers

    CLAO J. Off. Publ. Contact Lens Assoc. Ophthalmol. Inc

    (1997)
  • B. Caffery et al.

    Tear lipocalin and lysozyme in Sjogren and non-Sjogren dry eye

    Optom. Vis. Sci.

    (2008)
  • G. Carracedo et al.

    Diadenosine polyphosphates in tears of Sjogren syndrome patients

    Invest.Investig. Ophthalmol. Vis. Sci.

    (2010)
  • G. Carracedo et al.

    Changes in diadenosine polyphosphates during alignment-fit and orthokeratology rigid gas permeable lens wear

    Invest.Investig. Ophthalmol. Vis. Sci.

    (2012)
  • G. Carracedo et al.

    Diadenosine polyphosphates after laser in situ keratomileusis and photorefractive keratectomy refractive techniques

    Acta Ophthalmol.

    (2014)
  • Cited by (13)

    • Carbohydrate-based drugs launched during 2000−2021

      2022, Acta Pharmaceutica Sinica B
      Citation Excerpt :

      Diquafosol tetrasodium (44), developed by Inspire, Allergan, and Santen, is a second-generation uridine nucleotide, containing a symmetrical structure of two UDP (112) units, namely Up4U, for the treatment of dry eye disease. This molecule belongs to the dinucleoside 5′,5′-polyphosphates (DNP) class, which is commonly present in tears, aqueous humour, and retina, and works for ocular functions (Fig. 19A)452,453. Diquafosol tetrasodium (44) is an agonist of P2Y2 purinergic receptor which is a G protein-coupled receptor, and can stimulate secretion of mucins from the conjunctiva into tears442–445.

    • Current knowledge on the nucleotide agonists for the P2Y2 receptor

      2018, Bioorganic and Medicinal Chemistry
      Citation Excerpt :

      On the other hand, effects of Ap4A in the ocular surface are consist of four aspects which including tear secretion, tear components, corneal wound healing and epithelial permeability. The presence of Ap4A in tears of both animals and humans suggests that it may modify the physiology of ocular surface like aqueous component, mucins and proteins which results in the increasing of the tear volume in the ocular surface in experiments performed with New Zealand white rabbits.26 Ap4A present in tears has been shown to be very active to modify the rate of corneal wound healing by activating the P2Y2 receptor and accelerating corneal epithelial cell migration during with the activation of Mitogen-Activated Protein Kinase (MAPK) and cytoskeleton pathways.

    View all citing articles on Scopus
    1

    Percentage of work contributed by each author in the production of the manuscript is as follows: Gonzalo Carracedo 35%; Almudena Crooke 10%; Ana Guzman-Aranguez 10%; M.J. Perez de Lara 10%; Alba Martin-Gil 10%; Jesus Pintor 25%.

    View full text